-
Mashup Score: 1Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors - 10 month(s) ago
Key Points. The combinatorial dual-epitope DC vaccine is safe.This vaccine regimen induced an immune response in a minority of patients.One patient had an excep
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 0Addressing why veterans may be vaccine hesitant, ways to build patient-provider trust - 10 month(s) ago
WASHINGTON — When discussing COVID-19 vaccination with veterans who do not trust the health system, it is important to listen and not argue with them, according to a presentation at the American Thoracic Society International Conference.“I work with communities that are currently experiencing adverse relationships with health systems,” Isaretta Lee Riley, MD, MPH, assistant
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
Presented at #ATS2023: When discussing #COVID19 #vaccination with #veterans who do not trust the health system, it is important to listen and not argue with them. @ilrileyMD https://t.co/Cd2PTBqyvE
-
-
Mashup Score: 0Eligibility extended for shingles vaccination in England - 10 month(s) ago
The shingles vaccination programme in England is changing from September both on type of vaccine and who is eligible.
Source: Nursing in PracticeCategories: Latest Headlines, NursingTweet-
Eligibility for the #shingles vaccination is changing from September. Follow the link below to learn more about how eligibility for the #vaccination is being extended. ↘️ https://t.co/kbjeUBaqzR
-
-
Mashup Score: 2Updates from June 2023 Advisory Committee on Immunization Practices (ACIP) Meeting - 10 month(s) ago
NFID webinar will cover updates from the June 21-23, 2023, Advisory Committee on Immunization Practices (ACIP) meeting
Source: NFIDCategories: Infectious Disease, Latest HeadlinesTweet-
Join @NFIDVaccines on July 12th at 12:00 pm ET for a discussion highlighting updates from the June 21-23, 2023, Advisory Committee on Immunization Practices (ACIP) meeting on US #vaccination recommendations for children, adolescents, and adults. #ACIP https://t.co/ZZG1wq9xWs
-
-
Mashup Score: 0Eligibility extended for shingles vaccination in England - 10 month(s) ago
The shingles vaccination programme in England is changing from September both on type of vaccine and who is eligible.
Source: Nursing in PracticeCategories: Latest Headlines, NursingTweet-
💉 The shingles vaccination programme in England is changing from September, both on type of vaccine and who is eligible, with priority for over-50s who are immunocompromised. #Vaccination #Healthcare View the full article here ⬇️ https://t.co/etV8nFvdOg
-
-
Mashup Score: 0
An IDSA Reading Room selection
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
ICYMI: We examined viral dynamics and infectious virus shedding through daily longitudinal sampling in 23 adults infected with #SARS-CoV-2 at varying stages of #vaccination, including six fully vaccinated individuals. #InfectiousDisease @IDSAInfo https://t.co/GPYdfCXpYv https://t.co/iR0pSloCBa
-
-
Mashup Score: 0Short Film Looks to Build Awareness Around Meningitis B Vaccination - 10 month(s) ago
The film is part of a GSK campaign, Ask2BSure, that addresses this issue.
Source: ContagionLiveCategories: Infectious Disease, Latest HeadlinesTweet-
The film is part of a #GSK campaign, Ask2BSure, that addresses #Meningitis B #vaccination. https://t.co/6679S3Ytlo
-
-
Mashup Score: 1Israel detects 1st monkeypox case in 2023 - 10 month(s) ago
JERUSALEM, June 22 (Xinhua) — Israel has detected a case of monkeypox disease for the first time in 2023, the country’s Health Ministry said in a statement on Thursday.
Source: The StarCategories: Infectious Disease, Latest HeadlinesTweet-
#mpox is not over. #Israel reporting their first case of mpox of 2023 diagnosed in a man in his 50s traveling from Portugal to Israel. He contracted disease despite #vaccination. Before this, between May - October 2022, Israel reported 262 mpox cases https://t.co/IPdnpyAJeE
-
-
Mashup Score: 0Reactogenicity and safety of COVID-19 primary immunisation and booster vaccination regimens: a comparative observational cohort study - BMC Medicine - 10 month(s) ago
Background Since the beginning of the COVID-19 vaccination campaigns, recommendations regarding the vaccination have been very dynamic. Although the safety and efficacy of different vaccines have been analysed, data were scarce for vaccine regimens combining different vaccines. We therefore aimed to evaluate and compare the perceived reactogenicity and need for medical consultation after the most…
Source: BioMed CentralCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
A NEW comparative observational cohort study by Lisette Warkentin and colleagues @UniFAU @Uniklinikum_ER revealed differences in reactogenicity between the #COVID19 #vaccines and #vaccination regimens in Germany. Read the full story here➡️https://t.co/vjSmCnbx7e https://t.co/XuIzd3ocrq
-
-
Mashup Score: 0Understanding how health care providers can prompt vaccine uptake - 11 month(s) ago
WASHINGTON — There are different ways to promote vaccination, and provider-patient communication is a major component to addressing vaccine hesitancy, according to a presentation at the American Thoracic Society International Conference.“[There are] several levers for increasing vaccination, which can really map to different levels in the health care ecosystem, with vaccine
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
“[There are] several levers for increasing #vaccination, which can really map to different levels in the health care ecosystem," Kimberly A. Fisher, MD, MSc, at @UMassChan, said during an #ATS2023 presentation. https://t.co/M3ENpB1l8d
-
#AuthorChoice: Activity and safety of a combination of #DendriticCell #vaccination given with mAb and cytotoxic #immunotherapy for #HER2-expressing #BreastCancer | from @SeroBMT1 @UNCDeptMedicine | #FreetoRead #ReadTheJI #immunology #cancer 👉 https://t.co/1h0N44H5Qe https://t.co/0WSyVrkejo